Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MRNA Moderna > Company Executives
MRNA Moderna
Post Mkt Price
NamePositionSalaryService DateEducationAgeGenderUpdated
Mr. Stephane BancelDirector and Chief Executive Officer12.86M----49male03/09/2022
Mr. David W. MelineChief Financial Officer and Principal Accounting Officer9.27M----64male05/11/2022
Mr. Juan AndresChief Technical Operations and Quality Officer4.25M----57male03/09/2022
Mr. Marcello DamianiChief Digital and Operational Excellence Officer------52male03/09/2022
Ms. Shannon Thyme KlingerChief Legal Officer and Corporate Secretary------50female03/09/2022
Ms. Tracey FranklinChief Human Resources Officer------42female03/09/2022
Mr. Paul BurtonChief Medical Officer------53male03/09/2022
Ms. Kate CroninChief Brand Officer------56female03/09/2022
Dr. Noubar B. Afeyan, PhDChairman of the Board1.63M----59male03/09/2022
Dr. Stephen Hoge, M.D.President5.26M----46male03/09/2022
Ms. Elizabeth E. TallettIndependent Director594.93K----72female03/09/2022
Dr. Robert S. LangerIndependent Director586.80K----73male03/09/2022
Mr. Paul SaganIndependent Director588.30K----63male03/09/2022
Dr. Elizabeth G. Nabel, M.D.Independent Director633.39K----70female03/09/2022
Dr. Sandra J. Horning, M.D.Independent Director574.93K----73female03/09/2022
Mr. Stephen BerensonIndependent Director591.43K----61male03/09/2022
Dr. Francois NaderIndependent Director580.55K----65male03/09/2022
Company Overview More
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
CEO: --
Market: NASDAQ
Hot List
SymbolLatest price%Chg